![Stuart Gunzburg](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 455 300 $ in data 31/05/2026
Stuart Gunzburg is the founder of Nextract Pty Ltd. Dr. Gunzburg is currently Managing Director & Director at Metavone Ltd. Dr. Gunzburg is also Executive Director & Chief Scientific Officer at EVE Health Group Ltd., starting in 2025.
Dr. Gunzburg holds an MBA and a doctorate from The University of Western Australia.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 20/03/2026 | 27.510.581 ( 7,81% ) | 455 300 $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| EVE HEALTH GROUP LIMITED | Direttore Tecnico/Scientifico/R&S | 12/06/2025 |
Metavone Ltd.
 Metavone Ltd. BiotechnologyHealth Technology Discovers and develops therapeutic treatments for dementia and hormone related cancers | Amministratore Delegato | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 3 |
|---|---|
EVE Health Group Ltd.
 EVE Health Group Ltd. Pharmaceuticals: OtherHealth Technology Manufactures and retails health and wellness food products | Health Technology |
The University of Western Australia
 The University of Western Australia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Metavone Ltd.
Metavone Ltd. BiotechnologyHealth Technology Discovers and develops therapeutic treatments for dementia and hormone related cancers | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
